A citation-based method for searching scientific literature

Kristi D Graves, Patti Vegella, Elizabeth A Poggi, Beth N Peshkin, Angie Tong, Claudine Isaacs, Clinton Finch, Scott Kelly, Kathryn L Taylor, George Luta, Marc D Schwartz. Cancer Epidemiol Biomarkers Prev 2012
Times Cited: 52







List of co-cited articles
391 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: does time heal women's concerns?
Chanita Hughes Halbert, Jill E Stopfer, Jasmine McDonald, Benita Weathers, Aliya Collier, Andrea B Troxel, Susan Domchek. J Clin Oncol 2011
49
40


Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
25

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
25

Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
Iris van Oostrom, Hanne Meijers-Heijboer, Litanja N Lodder, Hugo J Duivenvoorden, Arthur R van Gool, Caroline Seynaeve, Conny A van der Meer, Jan G M Klijn, Bert N van Geel, Curt W Burger,[...]. J Clin Oncol 2003
191
25

Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.
Marc D Schwartz, Beth N Peshkin, Chanita Hughes, David Main, Claudine Isaacs, Caryn Lerman. J Clin Oncol 2002
175
23

A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.
David Cella, Chanita Hughes, Amy Peterman, Chih-Hung Chang, Beth N Peshkin, Marc D Schwartz, Lari Wenzel, Amy Lemke, Alfred C Marcus, Caryn Lerman. Health Psychol 2002
166
21

Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening.
Kelly A Metcalfe, Nida Mian, Melissa Enmore, Aletta Poll, Marcia Llacuachaqui, Sonia Nanda, Ping Sun, Kevin S Hughes, Steven A Narod. Breast Cancer Res Treat 2012
54
21

Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance.
Marc D Schwartz, Claudine Isaacs, Kristi D Graves, Elizabeth Poggi, Beth N Peshkin, Christy Gell, Clinton Finch, Scott Kelly, Kathryn L Taylor, Lauren Perley. Cancer 2012
90
19

Psychological distress and quality of life associated with genetic testing for breast cancer risk.
Ashley Wilder Smith, Angela Liegey Dougall, Donna M Posluszny, Tamara J Somers, Wendy S Rubinstein, Andrew Baum. Psychooncology 2008
50
20

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.
Suzanne C O'Neill, Christine Rini, Rachel E Goldsmith, Heiddis Valdimarsdottir, Lawrence H Cohen, Marc D Schwartz. Psychooncology 2009
70
19

The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal?
Tammy M Beran, Annette L Stanton, Lorna Kwan, Joyce Seldon, Julienne E Bower, Andrea Vodermaier, Patricia A Ganz. Ann Behav Med 2008
52
19

The hospital anxiety and depression scale.
A S Zigmond, R P Snaith. Acta Psychiatr Scand 1983
17

Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.
Sandra van Dijk, Daniëlle R M Timmermans, Hanne Meijers-Heijboer, Aad Tibben, Christi J van Asperen, Wilma Otten. J Clin Oncol 2006
60
17

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
17

Psychological Distress, Anxiety, and Depression of Cancer-Affected BRCA1/2 Mutation Carriers: a Systematic Review.
Johanna Ringwald, Christina Wochnowski, Kristin Bosse, Katrin Elisabeth Giel, Norbert Schäffeler, Stephan Zipfel, Martin Teufel. J Genet Couns 2016
39
23

Psychological impact of genetic testing in women from high-risk breast cancer families.
B Meiser, P Butow, M Friedlander, A Barratt, V Schnieden, M Watson, J Brown, K Tucker. Eur J Cancer 2002
92
15

Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort.
M Watson, C Foster, R Eeles, D Eccles, S Ashley, R Davidson, J Mackay, P J Morrison, P Hopwood, D G R Evans. Br J Cancer 2004
120
15

Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.
Marc D Schwartz, Caryn Lerman, Barbara Brogan, Beth N Peshkin, Chanita Hughes Halbert, Tiffani DeMarco, William Lawrence, David Main, Clinton Finch, Colette Magnant,[...]. J Clin Oncol 2004
189
13


Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers.
Kristi D Graves, Lari Wenzel, Marc D Schwartz, George Luta, Paul Wileyto, Steven Narod, Beth N Peshkin, Alfred Marcus, David Cella, Susan Powell Emsbo,[...]. Cancer Epidemiol Biomarkers Prev 2010
33
21

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
824
13

Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial.
Ranjit Manchanda, Kelly Loggenberg, Saskia Sanderson, Matthew Burnell, Jane Wardle, Sue Gessler, Lucy Side, Nyala Balogun, Rakshit Desai, Ajith Kumar,[...]. J Natl Cancer Inst 2014
102
13

Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing.
Kenneth P Tercyak, Beth N Peshkin, Barbara M Brogan, Tiffani DeMarco, Marie F Pennanen, Shawna C Willey, Colette M Magnant, Sarah Rogers, Claudine Isaacs, Marc D Schwartz. J Clin Oncol 2007
57
11

BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy.
Kathryn J Schlich-Bakker, Margreet G E M Ausems, Maria Schipper, Herman F J Ten Kroode, Carla C Wárlám-Rodenhuis, Jan van den Bout. Breast Cancer Res Treat 2008
31
19

Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
Joël Vos, Encarna Gómez-García, Jan C Oosterwijk, Fred H Menko, Reinoud D Stoel, Christi J van Asperen, Anna M Jansen, Anne M Stiggelbout, Aad Tibben. Psychooncology 2012
48
12

Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study.
Yvonne Brandberg, Kerstin Sandelin, Staffan Erikson, Göran Jurell, Annelie Liljegren, Annika Lindblom, Ann Lindén, Anna von Wachenfeldt, Marie Wickman, Brita Arver. J Clin Oncol 2008
141
11

Benefit finding in response to BRCA1/2 testing.
Carissa A Low, Julienne E Bower, Lorna Kwan, Joyce Seldon. Ann Behav Med 2008
27
22

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
11

Psychological consequences of predictive genetic testing: a systematic review.
M Broadstock, S Michie, T Marteau. Eur J Hum Genet 2000
234
11

A systematic review of perceived risks, psychological and behavioral impacts of genetic testing.
Jodi T Heshka, Crystal Palleschi, Heather Howley, Brenda Wilson, Philip S Wells. Genet Med 2008
219
11

Patient satisfaction with health care decisions: the satisfaction with decision scale.
M Holmes-Rovner, J Kroll, N Schmitt, D R Rovner, M L Breer, M L Rothert, G Padonu, G Talarczyk. Med Decis Making 1996
386
11

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
482
11

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003
11

Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award.
Mary-Claire King, Ephrat Levy-Lahad, Amnon Lahad. JAMA 2014
172
11

Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
Heidi S Lumish, Hallie Steinfeld, Carrie Koval, Donna Russo, Elana Levinson, Julia Wynn, James Duong, Wendy K Chung. J Genet Couns 2017
61
11

The Brief Symptom Inventory: an introductory report.
L R Derogatis, N Melisaratos. Psychol Med 1983
9

Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy.
Kelly A Metcalfe, Mary Jane Esplen, Vivek Goel, Steven A Narod. Psychooncology 2004
78
9

Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
L C Hartmann, D J Schaid, J E Woods, T P Crotty, J L Myers, P G Arnold, P M Petty, T A Sellers, J L Johnson, S K McDonnell,[...]. N Engl J Med 1999
912
9

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
B B Roa, A A Boyd, K Volcik, C S Richards. Nat Genet 1996
543
9

Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction.
Marc D Schwartz, Heiddis B Valdimarsdottir, Tiffani A DeMarco, Beth N Peshkin, William Lawrence, Jessica Rispoli, Karen Brown, Claudine Isaacs, Suzanne O'Neill, Rebecca Shelby,[...]. Health Psychol 2009
72
9

What factors may influence psychological well being at three months and one year post BRCA genetic result disclosure?
Nina Bosch, Núria Junyent, Neus Gadea, Joan Brunet, Teresa Ramon y Cajal, Asunción Torres, Begoña Graña, Angela Velasco, Esther Darder, Irene Mensa,[...]. Breast 2012
23
21

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.
Heidi D Nelson, Miranda Pappas, Bernadette Zakher, Jennifer Priest Mitchell, Leila Okinaka-Hu, Rongwei Fu. Ann Intern Med 2014
151
9

Experiences of Women Who Underwent Predictive BRCA 1/2 Mutation Testing Before the Age of 30.
Kate Brunstrom, Alexandra Murray, Marion McAllister. J Genet Couns 2016
24
20


American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
296
9

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
783
9


Validation of a decisional conflict scale.
A M O'Connor. Med Decis Making 1995
7

Distress and psychosocial needs of a heterogeneous high risk familial cancer population.
Tara E Power, John W Robinson, Peter Bridge, Francois P Bernier, Dawna M Gilchrist. J Genet Couns 2011
8
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.